Biomarkers as Predictive Tools in Toxicity Testing
暂无分享,去创建一个
Michael Balls | Benoît Schilter | Krys Bottrill | Francesco Branca | Sarah Oehlschlager | F. Branca | A. B. Hanley | D. Benford | S. Oehlschlager | M. Balls | B. Schilter | D. J. Benford | A. Bryan Hanley | Jean Jaques Castegnaro | Jaques Descotes | Kari Hemminiki | David Lindsay | K. Bottrill | D. Lindsay | J. Descotes | J. Castegnaro | Kari Hemminiki | Jaques | Descotes
[1] B. Hulka,et al. Biological markers in epidemiologic research. , 1988, Archives of environmental health.
[2] K. Setchell,et al. Dietary isoflavones: biological effects and relevance to human health. , 1999, The Journal of nutrition.
[3] D. Byar,et al. The study of markers of biological effect in cancer prevention research trials , 1992, International journal of cancer.
[4] J. Wahrendorf. Design of studies for validation of biomarkers of exposure and their effective use in environmental epidemiology. , 1995, Toxicology.
[5] J. Angerer,et al. Report on the status of the external quality-control programs for occupational-medical and environmental-medical toxicological analyses in biological materials in Germany , 1999, International archives of occupational and environmental health.
[6] Krys Bottrill,et al. The Use of Biomarkers as Alternatives to Current Animal Tests on Food Chemicals 1 , 1998, Alternatives to laboratory animals : ATLA.
[7] P. Schulte,et al. Validation of biological markers for quantitative risk assessment. , 1991, Environmental health perspectives.
[8] B B Brodie,et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.
[9] T. van Gent,et al. The cholesterol-raising diterpenes from coffee beans increase serum lipid transfer protein activity levels in humans. , 1997, Atherosclerosis.
[10] P. Kinney,et al. Application of reliability models to studies of biomarker validation. , 1994, Environmental health perspectives.
[11] D. Hattis. Use of biological markers and pharmacokinetics in human health risk assessment. , 1991, Environmental health perspectives.
[12] P Grandjean,et al. Biomarkers in epidemiology. , 1995, Clinical chemistry.
[13] A. Constable,et al. The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. , 1998, Carcinogenesis.
[14] B. Heinzow,et al. Biomarkers in epidemiological and toxicological nutrition research , 1997 .
[15] S. Thorgeirsson,et al. Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. , 1974, Pharmacology.
[16] J. A. Bond,et al. The use of biological markers in toxicology. , 1989, Critical reviews in toxicology.
[17] J. Ward,et al. Identification of needs in biomarker research. , 1996, Environmental health perspectives.
[18] Philip J. Landrigan,et al. Biological markers in environmental health research , 1987 .
[19] B B Brodie,et al. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. , 1973, The Journal of pharmacology and experimental therapeutics.